Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506

Blood. 2000 May 1;95(9):2733-41.

Abstract

The activation of blood cells, including T cells, triggers intracellular signals that control the expression of critical molecules, including cytokines and cytokine receptors. We show that T-cell receptor (TCR) ligation increases the cellular level of the protein linker for activation of T cells (LAT), a molecule critical for T-cell development and function. T-cell activation increased LAT messenger RNA, as determined by reverse transcription-polymerase chain reaction and by Northern blotting. The TCR-induced increase in LAT expression involved the activation of the serine/threonine kinases PKC and MEK, because inhibitors of these kinases blocked the increase in LAT. Accordingly, the PKC activator phorbol myristate acetate up-regulated LAT expression. Strikingly, the calcineurin inhibitors cyclosporin A (CsA) and FK506 strongly potentiated TCR-induced LAT expression, suggesting that the activation of calcineurin following TCR ligation negatively regulates LAT expression. Accordingly, Ca(++ )ionophores, which can activate calcineurin by increasing intracellular Ca(++), blocked the TCR-induced increase in cellular LAT. CsA and FK506 blocked the Ca(++ )ionophores' inhibitory effect on LAT expression. Notably, CsA and FK506 preferentially up-regulated TCR-induced LAT expression; under the same conditions, these compounds did not increase the expression of 14 other molecules that previously had been implicated in T-cell activation. These data show that TCR-induced LAT expression involves the activation of the PKC-Erk pathway and is negatively regulated by the activation of calcineurin. Furthermore, the potentiation of TCR-induced LAT expression by CsA and FK506 suggests that the action of these agents involves up-regulating the cellular level of critical signaling molecules. These findings may have important therapeutic implications. (Blood. 2000;95:2733-2741)

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • CD28 Antigens / physiology*
  • CD3 Complex / physiology*
  • Calcimycin / pharmacology
  • Calcineurin Inhibitors*
  • Carrier Proteins / genetics*
  • Cells, Cultured
  • Cyclosporine / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology*
  • Humans
  • Indoles / pharmacology
  • Jurkat Cells
  • Lymphocyte Activation*
  • Membrane Proteins*
  • Phosphoproteins / genetics*
  • Protein Kinase C / metabolism
  • Receptor-CD3 Complex, Antigen, T-Cell / physiology
  • T-Lymphocytes / immunology*
  • Tacrolimus / pharmacology*
  • Transcription, Genetic

Substances

  • Adaptor Proteins, Signal Transducing
  • CD28 Antigens
  • CD3 Complex
  • Calcineurin Inhibitors
  • Carrier Proteins
  • Enzyme Inhibitors
  • Flavonoids
  • Indoles
  • LAT protein, human
  • Membrane Proteins
  • Phosphoproteins
  • Receptor-CD3 Complex, Antigen, T-Cell
  • Calcimycin
  • Cyclosporine
  • Protein Kinase C
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Ro 31-8220
  • Tacrolimus